Skip to main content
Equibles

AMERIPRISE FINANCIAL INC

Position in ALLO — Allogene Therapeutics, Inc.

CIK 820027 MINNEAPOLIS, MN
Back to ALLO Full portfolio

Position in ALLO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$977,320
+$380,516 QoQ
Shares Held
469,866
+92.1% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 209 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. ALLO ranks #156 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,604,822 $1,293,893,227
2 INSM
INSMED Inc
 6,179,571 $658,865,856
3 JAZZ
Jazz Pharmaceuticals plc
 1,215,523 $292,904,576
4 RVMD
Revolution Medicines, Inc.
 1,039,702 $194,715,388
5 ARGX
Argenx SE
 181,464 $168,356,853
6 REGN
Regeneron Pharmaceuticals, Inc.
 227,457 $141,828,535
7 MDGL
Madrigal Pharmaceuticals, Inc.
 231,205 $124,145,521
8 BBIO
BridgeBio Pharma, Inc.
 1,551,663 $115,567,858

All Filings in ALLO

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $977,320 469,866
2026-03-31 $596,804 244,592
2025-03-31 $357,010 244,528
2024-12-31 $430,137 201,943
2024-09-30 $495,915 177,113
2024-06-30 $787,644 338,045
2024-03-31 $845,008 189,040
2023-12-31 $610,846 190,295
2023-09-30 $426,653 134,591
2023-06-30 $552,543 111,176
2023-03-31 $3,992,624 808,224
2022-12-31 $4,033,071 641,188
2022-09-30 $8,325,535 770,883
2022-06-30 $11,942,239 1,047,565
2022-03-31 $9,187,761 1,008,536
2021-12-31 $10,662,756 714,662
2021-09-30 $9,813,030 381,830
2021-06-30 $745,392 28,581
2021-03-31 $859,449 24,347
2020-12-31 $738,875 29,274
2020-09-30 $1,159,318 30,743
2020-06-30 $1,477,117 34,496